Test filters | DNDi

News

In the media

Press releases

Publications

Scientific articles

Statements

Stories

Videos

Viewpoints

In the media

27 Feb 2026

After CHMP nod, Moderna CEO applauds EU’s ‘rigorous scientific review’

Fierce Pharma

In the media

27 Feb 2026

EMA gives positive opinion for single-dose sleeping sickness medication

Citizen Digital

In the media

27 Feb 2026

Single-dose sleeping sickness pill clears major EU regulatory milestone

Capital FM

Press Releases Translations

27 Feb 2026

L’acoziborole Winthrop, développé par DNDi et Sanofi, reçoit l’avis positif de l’Agence Européenne des Médicaments (EMA) en tant que traitement à dose unique à trois comprimés pour la forme la plus fréquente de la maladie du sommeil

Press releases

27 Feb 2026

Acoziborole Winthrop, developed by DNDi and Sanofi, receives European Medicines Agency positive opinion as three-tablet, single-dose treatment for most common form of sleeping sickness

In the media

27 Feb 2026

Breakthrough single-dose treatment for sleeping sickness gets EU nod

KBC

In the media

27 Feb 2026

New sleeping sickness pill gets nod, paving the way for use in Africa

Associated Press

Scientific articles

27 Feb 2026

Evaluation of drug–drug interaction potential between the oral antibiotic zoliflodacin and the CYP3A4 inhibitor itraconazole: A phase 1 study in healthy participants

Clinical and Translational Science

In the media

27 Feb 2026

New pill has potential to eliminate deadly sleeping sickness

Bloomberg

In the media

27 Feb 2026

Maladie du sommeil : l’autorisation européenne d’un nouveau traitement laisse entrevoir une élimination de la maladie d’ici à 2030

Le Monde

In the media

27 Feb 2026

La maladie du sommeil bientôt éliminée ? Feu vert européen à un nouveau traitement

France 24

In the media

27 Feb 2026

‘Truly spectacular’ drug for sleeping sickness simplifies treatment, raising hopes for eradication

Science

Scientific articles

26 Feb 2026

A Computational Community Blind Challenge on Pan-Coronavirus Drug Discovery Data

Journal of Chemical Information and Modeling

In the media

26 Feb 2026

被忽视疾病的希望

China Philanthropy Magazine

Scientific articles

24 Feb 2026

Elimination of visceral leishmaniasis as a public health problem in Bangladesh: Lessons learned and questions remaining

PLOS Neglected Tropical Diseases

Scientific articles

24 Feb 2026

Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infections and associated risk factors among pregnant women and key populations in Kenya: A multi-centre cross-sectional study

PLOS Global Public Health

International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

After CHMP nod, Moderna CEO applauds EU’s ‘rigorous scientific review’

EMA gives positive opinion for single-dose sleeping sickness medication

Single-dose sleeping sickness pill clears major EU regulatory milestone

L’acoziborole Winthrop, développé par DNDi et Sanofi, reçoit l’avis positif de l’Agence Européenne des Médicaments (EMA) en tant que traitement à dose unique à trois comprimés pour la forme la plus fréquente de la maladie du sommeil

Acoziborole Winthrop, developed by DNDi and Sanofi, receives European Medicines Agency positive opinion as three-tablet, single-dose treatment for most common form of sleeping sickness

Breakthrough single-dose treatment for sleeping sickness gets EU nod

New sleeping sickness pill gets nod, paving the way for use in Africa

Evaluation of drug–drug interaction potential between the oral antibiotic zoliflodacin and the CYP3A4 inhibitor itraconazole: A phase 1 study in healthy participants

New pill has potential to eliminate deadly sleeping sickness

Maladie du sommeil : l’autorisation européenne d’un nouveau traitement laisse entrevoir une élimination de la maladie d’ici à 2030

La maladie du sommeil bientôt éliminée ? Feu vert européen à un nouveau traitement

‘Truly spectacular’ drug for sleeping sickness simplifies treatment, raising hopes for eradication

A Computational Community Blind Challenge on Pan-Coronavirus Drug Discovery Data

被忽视疾病的希望

Elimination of visceral leishmaniasis as a public health problem in Bangladesh: Lessons learned and questions remaining

Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infections and associated risk factors among pregnant women and key populations in Kenya: A multi-centre cross-sectional study

Learn more

Get in touch

Support us

Work with us